Like most drugs, Keytruda may cause mild or serious side ... If you have questions about this, talk with your doctor. If you have a rash along with any of these symptoms, or if your rash doesn ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

Germany-based BioNTech got into the space before the gold rush that was unleashed in September by the news that Akeso and ...

As with other drugs, Padcev can cause side effects, such as rash and hair loss ... be given alone or in combination with pembrolizumab (Keytruda). In Padcev clinical trials, the more common ...

NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England. Merck, Sharp, and Dohme (MSD)’s Keytruda (pembrolizumab ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...

NICE has given the green light for lung cancer drug Keytruda to be used as a routine treatment for certain patients in England. Merck, Sharp, and Dohme (MSD)’s Keytruda (pembrolizumab ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business. But Merck's vaccine that prevents cancer from HPV ...